Liu Fuyou, Liu Hong, Peng Youming, Liu Yinghong, Li Jun, Chen Xing
Nephrology Department, 2nd Xiangya Hospital, Central South University, Changsha City, Hunan Province, China.
Nephrology (Carlton). 2006 Feb;11(1):23-8. doi: 10.1111/j.1440-1797.2006.00530.x.
Transforming growth factor-beta(1) (TGF-beta(1)) is an important mediator of the fibrosis process. High expression of TGF-beta(1) is closely related to peritoneal fibrosis. RNA interference using short hairpin RNA (shRNA) can mediate sequence-specific inhibition of gene expression in mammalian cells. The aim of this study was to assess the effect of shRNA targeting TGF-beta(1) on the expression of TGF-beta(1) in human peritoneal mesothelial cells (HPMC).
TGF-beta(1) specific shRNA expression vectors were constructed and introduced to HPMC stimulated with 4.25% D-glucose (Gs) and 10 microg/mL of lipopolysaccharide (LPS). Expression of TGF-beta(1) mRNA was assessed by semiquantification reverse transcription polymerase chain reaction (RT-PCR). The TGF-beta(1) protein level in the culture supernatant was determined by sandwich enzyme-linked immunosorbent assay.
The expression of TGF-beta(1) was upregulated significantly in HPMC stimulated with 4.25% D-Gs and 10 microg/mL LPS P < 0.01. TGF-beta(1) expression in pcDU6 plasmid vector-mediated TGF-beta(1) shRNA groups were obviously downregulated when compared to the 4.25% D-Gs and 10 microg/mL LPS group (P < 0.01) and the pcDU6 void vector group (P < 0.05), with no significant difference among pcDU6 plasmid vector -mediated TGF-beta(1) shRNA groups (P > 0.05). No significant difference was found between teh pcDNA3.1(-) vector plasmid-mediated TGF-beta(1) antisense RNA group and pcDU6 void vector group (P > 0.05). The expression of TGF-beta(1) in pcDU6 plasmid vector-mediated TGF-beta(1) shRNA groups were obviously downregulated when compared to the pcDNA3.1(-) plasmid vector-mediated TGF-beta(1) antisense RNA group (P < 0.05).
TGF-beta(1)-specific shRNA can significantly inhibit the expression of TGF-beta(1) in HPMC stimulated with 4.25% D-Gs and 10 microg/mL LPS in HPMC. These results suggest the possible application of TGF-beta(1)-specific shRNA in preventing peritoneal fibrosis in patients receiving peritoneal dialysis.
转化生长因子-β1(TGF-β1)是纤维化过程的重要介质。TGF-β1的高表达与腹膜纤维化密切相关。使用短发夹RNA(shRNA)的RNA干扰可介导哺乳动物细胞中基因表达的序列特异性抑制。本研究旨在评估靶向TGF-β1的shRNA对人腹膜间皮细胞(HPMC)中TGF-β1表达的影响。
构建TGF-β1特异性shRNA表达载体,并将其导入用4.25% D-葡萄糖(Gs)和10μg/mL脂多糖(LPS)刺激的HPMC中。通过半定量逆转录聚合酶链反应(RT-PCR)评估TGF-β1 mRNA的表达。用夹心酶联免疫吸附测定法测定培养上清液中TGF-β1蛋白水平。
在用4.25% D-Gs和10μg/mL LPS刺激的HPMC中,TGF-β1的表达显著上调(P < 0.01)。与4.25% D-Gs和10μg/mL LPS组(P < 0.01)和pcDU6空载体组(P < 0.05)相比,pcDU6质粒载体介导的TGF-β1 shRNA组中TGF-β1的表达明显下调,pcDU6质粒载体介导的TGF-β1 shRNA组之间无显著差异(P > 0.05)。pcDNA3.1(-)载体质粒介导的TGF-β1反义RNA组与pcDU6空载体组之间无显著差异(P > 0.05)。与pcDNA3.1(-)质粒载体介导的TGF-β1反义RNA组相比,pcDU6质粒载体介导的TGF-β1 shRNA组中TGF-β1的表达明显下调(P < 0.05)。
TGF-β1特异性shRNA可显著抑制用4.25% D-Gs和10μg/mL LPS刺激的HPMC中TGF-β1的表达。这些结果提示TGF-β1特异性shRNA在预防接受腹膜透析患者的腹膜纤维化中可能具有应用价值。